Grand River Expands Manufacturing Capacity
Grand River Aseptic Manufacturing, a parenteral contract development and manufacturing organization (CDMO), has made its second major equipment purchase this year: a state-of-the-art Bausch+Ströbel fully integrated high-speed filling line with SKAN isolator.
The Bausch+Ströbel filler can fill 200 vials per minute and will more than triple Grand River's manufacturing capacity, maximizing flexibility in manufacturing solutions, increasing process efficiency and ensuring the highest level of sterility. The fully integrated fill line includes a vial washer, depyrogenation tunnel and filling machine and will fill vials ranging from 2mL to 50mL with 100% weight checks.
"GRAM continues to build our flexibility in the highly competitive CDMO market," said Nick Bykerk, vice president of business development and finance, Grand River. "Simultaneously, we are reinvesting in the development of our clinical-scale manufacturing. The combination of specialized clinical and commercial production with our analytical and development services offers a powerful solution to better meet the evolving needs of our clients."
The company is scheduling new projects starting in summer 2019. Tom Ross, president and chief executive officer of Grand River, said, "The fully integrated filling line is a significant capital investment capable of executing clients' complex parenteral manufacturing processes with the utmost precision. We look forward to serving our customers through additional investments in our facilities and finishing areas, including inspection, labeling and packaging."
Grand River's aggressive expansion plans also include the recent completion of a major land purchase agreement and the purchase of a new syringe filler.
"Grand River has always centered around quality and service, which has led to explosive growth," said Mr. Ross. "With Arlington Capital joining our company last November, we have the financial resources to invest in our customers through a planned expansion, new state-of-art injectable fill/finish equipment and additional highly trained staff."
To learn more about Grand River's parenteral capabilities, visit www.grandriverasepticmfg.com.
2026-09-03
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
CPHI Korea 2026: A Leading Gateway to Korea’s Pharmaceutical and Biopharma Market
-
Pharmaconex
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Beyond Compliance: Building Quality Maturity
-
Is the class solidified? From Biotech to Pharma
-
The IPO of the Largest Domestic Metronidazole API Manufacturer has Passed the Meeting
-
Progesterone Market Potential is Huge
-
PharmaReg AfriSummit
Recommend Reading
-
Fertilizer Costs Rise as Middle East Tensions Pressure Global Food Production
-
Fertilizer Costs Rise as Middle East Tensions Pressure Global Food Production
-
Global Trade Data for Epoxy Resin in 2025 Released: Asia Accounted for $640 Million in Imports, Vietnam Emerges as Top Buyer
-
Japanese Plastics Market Accelerates its Shifts to Recycled Materials and Bioplastics
-
MDI Price Surge Hits EMEAI: Is This a Market Correction or the Beginning of a Supply Crisis?
-
March Acetic Acid Market Strongly Rises in China
-
MTBE Market Trend in China Shows Weak Consolidation
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
China's phenol market trended upward in March, may remain high in April
-
Business Society: The Bisphenol A Market in March Shows a Trend of Sharp Rise Followed by Gradual Stabilization